Research ArticlePulmonary Hypertension

ACTRIIA-Fc rebalances activin/GDF versus BMP signaling in pulmonary hypertension

See allHide authors and affiliations

Science Translational Medicine  13 May 2020:
Vol. 12, Issue 543, eaaz5660
DOI: 10.1126/scitranslmed.aaz5660

Article Information

vol. 12 no. 543

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication September 19, 2019
  • Resubmitted January 22, 2020
  • Accepted for publication April 17, 2020
  • .

Author Information

  1. Lai-Ming Yung1,*,
  2. Peiran Yang1,*,
  3. Sachindra Joshi2,
  4. Zachary M. Augur1,
  5. Stephanie S. J. Kim1,
  6. Geoffrey A. Bocobo1,
  7. Teresa Dinter1,
  8. Luca Troncone1,
  9. Po-Sheng Chen1,3,
  10. Megan E. McNeil1,
  11. Mark Southwood4,
  12. Sergio Poli de Frias5,
  13. John Knopf2,
  14. Ivan O. Rosas5,
  15. Dianne Sako2,
  16. R. Scott Pearsall2,
  17. John D. Quisel2,
  18. Gang Li2,
  19. Ravindra Kumar2 and
  20. Paul B. Yu1,
  1. 1Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  2. 2Acceleron Pharma Inc., Cambridge, MA 02139, USA.
  3. 3Department of Internal Medicine, College of Medicine, National Cheng Kung University, Tainan City 704, Taiwan.
  4. 4Department of Pathology, Royal Papworth Hospital, Cambridge CB2 0AY, UK.
  5. 5Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  1. Corresponding author. Email: pbyu{at}bwh.harvard.edu
  • * These authors contributed equally to this work.

Altmetric

Article usage

Article usage: May 2020 to November 2020

AbstractFullPdf
May 20204518973251
Jun 202044592105
Jul 20203366854
Aug 20202754354
Sep 20202425772
Oct 20202114962
Nov 20201584549

Stay Connected to Science Translational Medicine